Health
New listings – Australian Journal of Pharmacy
The Health Minister has highlighted new PBS listings from Monday, March 1, including drugs to treat MS, asthma and diabetes From March 1, Zeposia and Atecture Breezhaler…
From March 1, Zeposia and Atecture Breezhaler will be listed on the PBS for the first time, and Trulicity will have its PBS listing extended, Greg Hunt said.
Zeposia (ozanimod) is used to treat relapsing remitting multiple sclerosis (RRMS), a chronic disease that attacks the central nervous system, and for which a cure is yet to be found, the Minister said in a statement.
Over 25,600 people in Australia have multiple sclerosis, and it affects each person differently, with more than 10 Australians…
Continue Reading
